Skip to main content

Nova Scotia to cover the cost of cystic fibrosis drug Trikafta

Share
HALIFAX -

Nova Scotia's health minister says the government will cover the cost of the cystic fibrosis drug Trikafta.

Michelle Thompson says she expects the drug to be on the provincial formulary by the end of November.

Thompson, who announced the decision in the legislature on Thursday, says the current list price for a 28-day supply of Trikafta is about $23,000.

Last month, Ontario, Alberta and Saskatchewan announced they would pay for the drug, which costs roughly $300,000 a year per patient at its list price under those provinces' publicly funded drug programs.

Cystic Fibrosis Canada has called Trikafta the "biggest innovation in cystic fibrosis treatment," and the group has noted that research indicates the drug could be effective in 90 per cent of patients.

Nova Scotia's decision affects more than 180 patients in that province, while Cystic Fibrosis Canada estimates about 4,300 Canadians have the disease.

This report by The Canadian Press was first published Oct. 15, 2021.

CTVNews.ca Top Stories

Do these exercises for core strength if you can't stomach doing planks

Planks are one of the most effective exercises for strengthening your midsection, as they target all of your major core muscles: the transverse abdominis, rectus abdominis, external obliques and internal obliques. Yet despite the popularity of various 10-minute plank challenges, planking is actually one of the most dreaded core exercises, according to many fitness experts.

Stay Connected